Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Preiss

Showing results (21-30 of 160) with videos related to

Pageof 16
Sort By:
The Lancet. Diabetes & Endocrinology|May 28, 2018
Research digest: assessment and risks of obesityNaveed Sattar, David Preiss
Current Opinion in Lipidology|September 8, 2011
Statins and the risk of new-onset diabetes: a review of recent evidenceDavid Preiss, Naveed Sattar
Current Opinion in Lipidology|January 1, 2015
Classification of reported statin intoleranceDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|February 8, 2018
Research digest: progress in microvascular complicationsNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|October 18, 2019
Research digest: new horizons in heart failure therapyNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|March 24, 2019
Research digest: new insights into established risk pathwaysDavid Preiss, Naveed Sattar
Lancet (London, England)|June 28, 2011
The case for diabetes screening: ADDITION-EuropeDavid Preiss, Naveed Sattar
Annals of Clinical Biochemistry|June 19, 2015
Biochemistry laboratories should routinely report non-HDL-cholesterolDavid Preiss, Dermot Neely
The Lancet. Diabetes & Endocrinology|December 13, 2016
Research digestDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|September 30, 2018
Research digest: CV trials in diabetes-looking aheadDavid Preiss, Naveed Sattar
Pageof 16

Showing results (21-30 of 160) with videos related to

Sort By:
Pageof 16
The Lancet. Diabetes & Endocrinology|May 28, 2018
Research digest: assessment and risks of obesityNaveed Sattar, David Preiss
Current Opinion in Lipidology|September 8, 2011
Statins and the risk of new-onset diabetes: a review of recent evidenceDavid Preiss, Naveed Sattar
Current Opinion in Lipidology|January 1, 2015
Classification of reported statin intoleranceDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|February 8, 2018
Research digest: progress in microvascular complicationsNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|October 18, 2019
Research digest: new horizons in heart failure therapyNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|March 24, 2019
Research digest: new insights into established risk pathwaysDavid Preiss, Naveed Sattar
Lancet (London, England)|June 28, 2011
The case for diabetes screening: ADDITION-EuropeDavid Preiss, Naveed Sattar
Annals of Clinical Biochemistry|June 19, 2015
Biochemistry laboratories should routinely report non-HDL-cholesterolDavid Preiss, Dermot Neely
The Lancet. Diabetes & Endocrinology|December 13, 2016
Research digestDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|September 30, 2018
Research digest: CV trials in diabetes-looking aheadDavid Preiss, Naveed Sattar
Pageof 16